Literature DB >> 23237927

A clinicopathological study of resected small-sized squamous cell carcinomas of the peripheral lung: prognostic significance of serum carcinoembryonic antigen levels.

Takuya Nagashima1, Yukinori Sakao, Mingyon Mun, Yuichi Ishikawa, Ken Nakagawa, Munetaka Masuda, Sakae Okumura.   

Abstract

PURPOSE: The purpose of this retrospective study was to evaluate common clinicopathological factors and clarify the prognostic factors of small-sized peripheral-lung squamous cell carcinomas.
METHODS: We retrospectively reviewed 71 patients with peripheral squamous cell carcinoma ≤3 cm in diameter, who were surgically treated between January 1989 and December 2010. Patients undergoing partial lung resection without lymph node dissection were excluded. The median follow-up for living patients was 63 months.
RESULTS: The overall 3- and 5-year survival rates were 83.9% and 74.7%, respectively.Although the ROC curve of serum carcinoembryonic antigen (CEA) levels showed marginally significance (P = 0.050), multivariate analyses revealed that age (P = 0.043), lymph node metastasis (P = 0.004), and preoperative serum carcinoembryonic antigen (CEA) level (P = 0.037) were independent prognostic factors. For pathologic N0 patients, there was a significant difference for recurrence-free survival based on CEA levels: patients with normal CEA levels (n = 40), 5-year-recurrence-free rate = 93.5%;elevated CEA (n = 14), 5-year-recurrence-free rate = 72.7% (P = 0.0160). The distribution of tumor cells immunoreactive for CEA was significantly associated with serum CEA levels (P = 0.033).
CONCLUSION: Age, lymph node metastasis, and serum CEA level are independent prognostic factors for small-sized peripheral-lung squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23237927     DOI: 10.5761/atcs.oa.12.01843

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  10 in total

1.  Clinicopathological features of small-sized peripheral squamous cell lung cancer.

Authors:  Takayuki Kosaka; Kimihiro Shimizu; Seshiru Nakazawa; Misaki Iijima; Yoichi Ohtaki; Yoko Azuma; Kai Obayashi; Toshiteru Nagashima; Toshiki Yajima; Akira Mogi; Hiroyuki Kuwano; Ken Shirabe
Journal:  Mol Clin Oncol       Date:  2019-11-18

Review 2.  Prognostic and predictive biomarkers in early stage NSCLC: CTCs and serum/plasma markers.

Authors:  Philip A J Crosbie; Rajesh Shah; Yvonne Summers; Caroline Dive; Fiona Blackhall
Journal:  Transl Lung Cancer Res       Date:  2013-10

3.  Ideal prognostic model in lung squamous cell carcinoma.

Authors:  Tomonari Kinoshita
Journal:  Transl Lung Cancer Res       Date:  2020-06

4.  Good response of malignant pleural effusion from carcinoma of unknown primary site to the anti-tuberculosis therapy: a case report.

Authors:  Qihua Gu; Chengping Hu; Jingjing Qu
Journal:  Int J Clin Exp Pathol       Date:  2013-04-15

5.  Prognostic model based on circular RNA circPDK1 for resected lung squamous cell carcinoma.

Authors:  Xiao Sun; Maolong Wang; Rongjian Xu; Dongyang Zhang; Ao Liu; Yuanyong Wang; Tong Lu; Yanlu Xin; Yandong Zhao; Yunpeng Xuan; Tong Qiu; Hao Wang; Shicheng Li; Yang Wo; Dahai Liu; Jinpeng Zhao; Bo Fu; Yaliang Lan; Yudong Han; Wenjie Jiao
Journal:  Transl Lung Cancer Res       Date:  2019-12

6.  Restrictive ventilatory impairment is associated with poor outcome in patients with cT1aN0M0 peripheral squamous cell carcinoma of the lung.

Authors:  Hiroyuki Tao; Junichi Soh; Hiromasa Yamamoto; Toshiya Fujiwara; Tsuyoshi Ueno; Makio Hayama; Mikio Okazaki; Ryujiro Sugimoto; Motohiro Yamashita; Yoshifumi Sano; Kazunori Okabe; Motoki Matsuura; Kazuhiko Kataoka; Shigeharu Moriyama; Shinichi Toyooka; Shinichiro Miyoshi
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

7.  The changing anatomic position of squamous cell carcinoma of the lung - a new conundrum.

Authors:  William Krimsky; Nargiz Muganlinskaya; Saiyad Sarkar; Manasa Vulchi; Pujan Patel; Suman Rao; Joel Hammer; Ruth Evans; Muhammad Qureshi; Daniel Harley
Journal:  J Community Hosp Intern Med Perspect       Date:  2016-12-15

8.  [Variations in Serum CEA and CYFRA21-1 Levels Before and After Surgery Facilitate Prognosis of Non-small Cell Lung Cancer Patients].

Authors:  Xinchun Duan; Yong Cui; Min Gong; Feng Tian; Guan Shi; Bingqun Wu; Mingliang Liu; Jiayun Guo; Yuanyuan Kong
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2015-06

9.  Clinical efficacy and safety evaluation of pemetrexed combined with radiotherapy in treatment of patients with lung adenocarcinoma brain metastasis.

Authors:  Guoqiao Zhang; Rong Zeng; Kai Wang; Yinzhuoyang A; Linhai Li; Kunmei Gong
Journal:  Oncol Lett       Date:  2019-01-04       Impact factor: 2.967

10.  Prognostic significance of postoperative serum carcinoembryonic antigen levels in patients with completely resected pathological-stage I non-small cell lung cancer.

Authors:  Yoshiki Kozu; Tomohiro Maniwa; Shoji Takahashi; Mitsuhiro Isaka; Yasuhisa Ohde; Takashi Nakajima
Journal:  J Cardiothorac Surg       Date:  2013-04-22       Impact factor: 1.637

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.